FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to oxime cholest-4-en-3-one derivatives of formula (I) and pharmaceutically acceptable salts and optical isomers thereof, and using them as cytoprotective drugs, as well as a based pharmaceutical composition. The radical values in general formula 
are presented in the patent claim.
EFFECT: compounds may be used as a cytoprotective drugs, including neuroprotective, cardioprotective and/or hepatoprotective drugs, a drug for protecting kidney cells, muscle cells, for treating or preventing necrosis and/or pathological apoptosis and/or necroptosis, and as a marker or labelling agent.
34 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL OXIME DERIVATIVES OF 3,5-SECO-4-NOR-CHOLESTANE, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND METHOD FOR PRODUCTION THEREOF | 2009 |
|
RU2508289C2 |
| NEW DERIVATIVES OF 3,5-SECO-4-NORCHOLESTANE AND THEIR APPLICATION | 2005 |
|
RU2398764C2 |
| SMALL MOLECULE OF INHIBITORS OF ENZYMATIC ACTIVITY OF ROTAMASE | 1996 |
|
RU2186770C2 |
| SMALL MOLECULES AS ROTAMASE ENZYME ACTIVITY INHIBITORS | 1996 |
|
RU2269514C9 |
| AGENT FOR INHIBITION OF INCREASE IN INTRA-NEURAL CALCIUM CONCENTRATION | 2019 |
|
RU2783208C2 |
| 8-OXY-QUINOLINE DERIVATIVES AS BRADYKININ B2 RECEPTOR MODULATORS | 2008 |
|
RU2512541C2 |
| DIKETONES AND HYDROXYKETONES AS ACTIVATORS OF CATENIN SIGNALLING PATHWAY | 2011 |
|
RU2592694C2 |
| IMMUNODEPRESSANT AND ANTICANCER DRUG CONTAINING HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT | 2006 |
|
RU2443441C2 |
| SELECTIVE BUTYRYLCHOLIN ESTERASE INHIBITORS | 2005 |
|
RU2386627C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING VERBENOL DERIVATIVE FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASE | 2013 |
|
RU2611349C2 |
